Wauwatosa, WI, United States of America

Henry Bordas-Murphy


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Henry Bordas-Murphy

Introduction

Henry Bordas-Murphy is an accomplished inventor based in Wauwatosa, Wisconsin. With a notable patent to his name, he has contributed significantly to the field of medical therapeutics. His innovative work primarily focuses on the delivery of polyunsaturated fatty acids and their derivatives, which hold important therapeutic applications.

Latest Patents

Henry Bordas-Murphy holds a patent for "Compositions and methods for delivery of polyunsaturated fatty acid derivatives and analogs." This invention provides a system that enables the oral delivery of therapeutics derived from polyunsaturated fatty acids (PUFAs), including a variety of metabolites and derivatives. The delivery system utilizes a vehicle comprising purified docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), which can be in triglyceride or ester forms. He also incorporates various supportive components such as antioxidants and solubilizers to enhance the effectiveness of the delivery system.

Career Highlights

Henry's work has been primarily associated with Cytometix, Inc., where he has applied his expertise to explore the potential of PUFAs in medical treatments. His commitment to innovation in therapeutic delivery systems demonstrates a robust understanding of both science and practical applications in healthcare.

Collaborations

Henry collaborates with esteemed colleagues such as Lane Brostrom and John Russell Falck. Together, they contribute to the ongoing research and development efforts within Cytometix, Inc., focusing on advancing the field of therapeutic delivery systems.

Conclusion

Henry Bordas-Murphy exemplifies the spirit of innovation through his pioneering work in the delivery of polyunsaturated fatty acid derivatives. His patent stands as a testament to his contributions to the medical field, illustrating the potential for improved therapeutic approaches. As he continues his work at Cytometix, Inc., the future holds promise for further advancements in this vital area of research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…